object
confirm
use
convent
molecular
detect
method
expand
studi
younger
children
studi
design
one
hundr
thirtytwo
nasal
aspir
children
hospit
sever
attack
asthma
studi
infant
mean
age
month
children
mean
age
year
accord
viru
viral
isol
techniqu
immunofluoresc
assay
ifa
use
detect
rhinoviru
enteroviru
respiratori
syncyti
rs
viru
adenoviru
coronaviru
influenza
parainfluenza
viru
polymeras
chain
reaction
pcr
assay
use
detect
rhinoviru
enteroviru
rs
viru
adenoviru
coronaviru
chlamydia
pneumonia
mycoplasma
pneumonia
result
use
ifa
viral
isol
techniqu
virus
detect
case
pcr
techniqu
nucleic
acid
sequenc
viru
chlamydia
pneumonia
mycoplasma
pneumonia
obtain
case
combin
convent
molecular
techniqu
detect
posit
sampl
two
organ
identifi
nasal
sampl
case
percentag
detect
higher
younger
group
frequent
detect
agent
rhinoviru
rs
viru
use
pcr
rather
convent
techniqu
detect
rate
increas
rhinoviru
rs
viru
infect
respect
detect
level
organ
follow
enteroviru
influenza
viru
chlamydia
pneumonia
adenoviru
coronaviru
parainfluenza
viru
mycoplasma
pneumonia
respect
conclus
result
confirm
previous
report
high
frequenc
rhinoviru
detect
asthmat
exacerb
children
also
point
frequenc
rs
viru
detect
emphas
fact
pcr
assay
may
necessari
diagnos
respiratori
infect
asthma
first
epidemiolog
data
establish
relationship
viral
infect
asthma
obtain
viral
isol
serolog
techniqu
viral
infect
identifi
case
childhood
adult
pattemor
et
al
three
frequent
isol
virus
rhinoviru
respiratori
syncyti
rs
viru
parainfluenza
viru
detect
case
respect
recent
combin
convent
detect
method
molecular
techniqu
johnston
et
al
publish
interest
data
incid
viral
infect
exacerb
asthma
children
overal
detect
rate
rhinoviru
enteroviru
coronaviru
detect
case
respect
studi
cohort
expand
children
less
year
age
diagnost
method
differ
convent
viral
molecular
techniqu
use
detect
rs
viru
rhinoviru
enteroviru
adenoviru
coronaviru
detect
coronaviru
chlamydia
pneumonia
mycoplasma
pneumonia
molecular
analysi
alon
use
detect
influenza
viru
parainfluenza
viru
carri
isol
techniqu
immunofluoresc
assay
ifa
studi
includ
children
suffer
acut
attack
asthma
diseas
resist
drug
treatment
prescrib
gener
practition
children
requir
hospit
due
sever
ill
total
nasal
aspir
collect
respect
specimen
collect
first
day
hospitalis
obtain
day
later
children
divid
two
group
infant
mean
age
month
rang
older
children
mean
age
year
rang
mean
number
asthmat
exacerb
rang
former
group
children
rang
second
group
mean
time
two
asthmat
exacerb
patient
month
infant
month
older
group
children
convent
method
carri
fresh
specimen
includ
viral
isol
techniqu
mdck
cell
ifa
nasal
smear
use
monoclon
antibodi
imagen
dako
uk
influenza
viru
b
parainfluenza
viru
rs
viru
adenoviru
coronaviru
argen
franc
nasal
aspir
resuspend
ml
viral
transport
medium
ml
use
ifa
ml
viral
isol
techniqu
isol
virus
mdck
cell
line
perform
use
previous
report
procedur
freymuth
et
al
ifa
use
identifi
influenza
viru
rs
viru
parainfluenza
viru
adenoviru
enteroviru
dako
uk
cell
cultur
rhinoviru
identifi
acid
stabil
test
rs
viru
subgroup
b
identifi
monoclon
antibodi
previous
report
freymuth
et
al
type
enteroviru
carri
utilis
neutralis
antibodi
eurobio
franc
molecular
techniqu
carri
frozen
sampl
one
posit
sever
neg
control
includ
infecti
agent
treat
ident
viru
sampl
throughout
nucleic
acid
extract
rnazol
b
bioprob
franc
rna
virus
chelex
procedur
dna
agent
previous
describ
freymuth
et
al
polymeras
chain
reaction
pcr
retrotranscript
pcr
rtpcr
follow
intern
probe
hybrid
use
detect
sequenc
rs
viru
adenoviru
chlamydia
pneumonia
mycoplasma
pneumonia
primer
probe
tabl
molecular
procedur
previous
defin
assess
studi
use
detect
rs
viru
freymuth
et
al
adenoviru
hierholz
et
al
chlamydia
pneumonia
petitjean
et
al
mycoplasma
pneumonia
de
barbeyrac
et
al
detect
coronaviru
primer
probe
select
laboratori
report
sequenc
gene
obtain
gene
bank
pcr
amplif
product
detect
agaros
gel
electrophoresi
identifi
accord
band
locat
compar
molecular
scale
band
bp
rs
viru
bp
adenoviru
chlamydia
pneumonia
bp
mycoplasma
pneumonia
bp
coronaviru
bp
coronaviru
detect
follow
dna
enzym
immunoassay
genetik
deia
sorin
final
test
base
hybrid
amplifi
dna
singl
strand
dna
biotinyl
probe
specif
agent
coat
wall
microtit
plate
streptavidin
biotin
bond
hybrid
probe
dna
detect
use
antidsdna
monoclon
antibodi
addit
enzym
tracer
antimous
immunoglobulin
g
igg
conjug
horseradish
peroxidas
assay
perform
recommend
manufactur
index
valu
defin
od
sampl
valueod
cutoff
valu
rs
viru
subgroup
b
classifi
pcr
rhinoviru
enteroviru
amplif
protocol
slightli
differ
three
primer
use
simultan
gama
et
al
nhrv
et
al
rtpcr
assay
mamm
amplifi
product
detect
electrophoresi
identifi
one
band
bp
case
enteroviru
two
band
bp
case
rhinoviru
final
result
correl
analysi
serolog
result
viral
chlamydia
pneumonia
mycoplasma
pneumonia
infect
sinc
retrospect
studi
blood
sampl
avail
use
convent
techniqu
ifa
viral
isol
techniqu
virus
detect
nasal
aspir
tabl
pcr
techniqu
nucleic
acid
sequenc
viru
chlamydia
pneumonia
mycoplasma
pneumonia
obtain
case
combin
convent
molecular
techniqu
detect
posit
specimen
two
organ
identifi
nasal
sampl
case
fourteen
rhinoviru
detect
associ
nine
rs
viru
two
coronaviru
one
enteroviru
one
chlamydia
pneumonia
one
mycoplasma
pneumonia
respect
six
rs
viru
associ
four
adenoviru
one
coronaviru
one
chlamydia
pneumonia
five
enteroviru
associ
two
adenoviru
one
coronaviru
one
chlamydia
pneumonia
one
parainfluenza
viru
two
chlamydia
pneumonia
associ
one
influenza
viru
one
mycoplasma
pneumonia
comparison
result
accord
children
age
show
percentag
viral
chlamydia
pneumonia
mycoplasma
pneumonia
detect
equal
vs
two
group
higher
level
posit
identif
younger
children
confirm
use
convent
techniqu
vs
probabl
reflect
broader
rang
infect
children
experienc
first
year
life
postacut
nasal
sampl
collect
children
rhinoviru
detect
acut
postacut
nasal
sampl
two
case
found
postacut
sampl
eight
case
two
children
infect
influenza
viru
two
other
infect
rs
viru
one
shed
respect
viru
postacut
control
result
indic
virus
could
shed
longer
interv
day
moreov
mean
time
two
asthmat
exacerb
children
least
month
prolong
shed
virus
like
except
studi
tabl
detail
detect
rate
virus
chlamydia
pneumonia
mycoplasma
pneumonia
detect
rate
agent
greater
use
molecular
rather
convent
techniqu
vs
respect
pcr
assay
design
natur
highli
sensit
detect
pathogen
poorli
detect
cultur
immunoassay
agent
includ
rhinoviru
coronaviru
chlamydia
pneumonia
mycoplasma
pneumonia
detect
rhinoviru
increas
use
pcr
techniqu
distinct
cultur
vs
among
six
coronaviru
pcrposit
sampl
five
coronaviru
one
coronaviru
none
ifaposit
chlamydia
pneumonia
mycoplasma
pneumonia
sought
pcr
assay
previous
document
low
effici
direct
detect
techniqu
isol
molecular
techniqu
also
improv
detect
rate
virus
usual
detect
convent
assay
rs
viru
adenoviru
enteroviru
exampl
rs
viru
pcrposit
sampl
ifa
viral
isol
techniqu
neg
two
six
adenoviru
pcrposit
sampl
ifa
viral
isol
techniqu
neg
retrospect
studi
blood
sampl
avail
children
none
result
pcr
assay
could
correl
serolog
analys
twothird
report
exacerb
asthma
posit
infecti
agent
use
combin
convent
molecular
techniqu
point
tabl
frequent
detect
agent
rhinoviru
rs
viru
respect
moreov
detect
correl
epidemiolog
pattern
virus
rs
viru
case
obtain
octob
march
wherea
detect
rhinoviru
case
spread
year
comparison
result
accord
children
age
show
rhinoviru
detect
frequent
older
children
infant
vs
rs
viru
detect
frequent
infant
vs
comparison
result
accord
techniqu
show
detect
rate
pcr
assay
relat
convent
techniqu
clearli
improv
older
children
comparison
younger
vs
rhinoviru
vs
rs
viru
level
detect
studi
respiratori
agent
rang
follow
enteroviru
seven
influenza
viru
four
viru
type
three
viru
type
b
six
chlamydia
pneumonia
six
adenoviru
six
coronaviru
one
viru
five
viru
five
parainfluenza
viru
one
viru
type
one
viru
type
three
viru
type
three
mycoplasma
pneumonia
one
herp
simplex
viru
combin
convent
molecular
techniqu
infecti
organ
identifi
case
studi
result
similar
obtain
johnston
et
al
identifi
virus
report
episod
asthmat
exacerb
data
indic
type
incid
infecti
agent
identifi
associ
acut
asthma
differ
usual
found
childhood
acut
respiratori
ill
ie
respiratori
virus
chlamydia
pneumonia
mycoplasma
pneumonia
freymuth
et
al
jen
et
al
low
isol
rate
rang
found
convent
respiratori
pathogen
name
influenza
viru
parainfluenza
viru
adenoviru
coronaviru
enteroviru
chlamydia
pneumonia
mycoplasma
pneumonia
addit
note
rhinoviru
rs
viru
detect
frequent
agent
virus
found
case
respect
observ
strengthen
season
distribut
two
pathogen
rs
viru
infect
observ
winter
period
wherea
rhinoviru
infect
distribut
year
freymuth
et
al
view
acut
exacerb
asthma
could
specif
associ
certain
virus
consist
studi
past
year
recent
studi
johnston
et
al
children
nicholson
et
al
adult
howev
specif
rate
rhinoviru
detect
differ
studi
johnston
et
al
report
specif
detect
rate
rhinoviru
contrast
rate
studi
case
due
unidentifi
picornaviru
classifi
possibl
rhinoviru
rais
possibl
overal
rate
rhinoviru
detect
could
similar
one
obtain
studi
johnston
et
al
although
primer
use
two
studi
detect
picornaviru
sequenc
differ
detect
rate
rhinoviru
could
relat
probe
primer
use
specif
identifi
rhinoviru
pcr
product
asthma
use
convent
techniqu
alon
detect
rate
infecti
agent
exceed
pattemor
et
al
develop
use
highli
sensit
molecular
techniqu
hypothes
rate
well
rang
infecti
agent
associ
exacerb
asthma
would
increas
inde
confirm
johnston
et
al
rate
viral
detect
pcr
base
assay
increas
also
previous
report
molecular
techniqu
sensit
ifa
viral
isol
detect
rs
viru
rhinoviru
adenoviru
parainfluenza
viru
nasal
specimen
collect
infant
bronchiol
freymuth
et
al
present
studi
confirm
observ
despit
obviou
use
molecular
techniqu
viral
isol
remain
gold
standard
virus
influenza
viru
molecular
method
yet
fulli
assess
detect
author
document
rs
viru
infect
asthmat
exacerb
contrast
rate
identifi
studi
conflict
result
may
relat
differ
age
group
differ
sensit
assay
use
result
underor
overestim
true
viral
rate
infect
rs
viru
identifi
frequent
respiratori
pathogen
earli
infanc
surpris
detect
frequent
children
studi
younger
rang
age
year
johnston
studi
rang
age
year
moreov
studi
detect
rate
higher
infant
older
children
discrep
may
also
relat
use
pcr
assay
studi
allow
increas
rs
viru
detect
infant
older
children
respect
johnston
et
al
document
coronaviru
infect
case
contrast
rate
studi
may
explain
use
pcr
serolog
former
studi
use
pcr
detect
posit
case
import
evalu
pathogen
relationship
detect
infecti
organ
develop
acut
asthma
firstli
detect
rs
viru
rhinoviru
upper
respiratori
tract
children
specif
link
infect
bronchial
inflamm
contribut
viralinduc
exacerb
asthma
knew
epitheli
cell
respiratori
tract
princip
host
main
common
respiratori
virus
littl
doubt
upper
lower
airway
tissu
simultan
infect
respiratori
diseas
due
agent
particularli
rs
viru
parainfluenza
viru
adenoviru
addit
sever
report
establish
rhinoviru
may
also
lower
respiratori
tract
pathogen
infant
rhinoviru
associ
lower
respiratori
tract
syndrom
bronchiol
pneumonia
freymuth
et
al
kellner
et
al
evid
possibl
lower
respiratori
tract
localis
rhinoviru
rna
detect
bronchoalveolar
lavag
volunt
experiment
inocul
gern
et
al
therefor
may
suggest
rs
viru
rhinoviru
infect
upper
airway
well
viral
chlamydia
pneumonia
mycoplasma
pneumonia
infect
could
simultan
infect
lower
airway
caus
exacerb
asthma
secondli
signific
presenc
genom
sequenc
infecti
agent
nasal
aspir
particularli
viral
detect
use
viral
isol
techniqu
ifa
neg
need
discuss
find
pcr
rsposit
cultur
ifa
rsneg
case
n
may
due
sever
caus
one
possibl
could
falseposit
result
relat
contamin
carryov
pcr
product
howev
strict
guidelin
gener
handl
pcr
procedur
appli
studi
like
explan
may
convent
techniqu
fail
detect
low
level
viru
could
detect
highli
sensit
pcr
techniqu
previous
demonstr
bronchiol
true
rsposit
pcr
result
inde
exist
case
miss
viral
isol
ifa
johnston
et
al
thing
may
also
happen
acut
exacerb
asthma
import
underlin
howev
pcr
techniqu
theoret
unabl
differenti
genuin
respiratori
infect
longterm
carriag
latent
infect
viru
differ
situat
posit
ifa
viral
isol
techniqu
result
detect
viral
antigen
infecti
particl
repres
activ
viral
replic
shown
use
convent
isol
techniqu
mean
durat
shed
rs
virusinfect
patient
day
rang
day
hall
et
al
volunt
inocul
rhinoviru
viru
shed
nasopharynx
last
day
dougla
et
al
averag
period
time
two
asthmat
exacerb
patient
least
month
studi
may
assum
detect
rs
viru
rhinoviru
relat
prolong
shed
virus
howev
inform
yet
avail
possibl
true
latent
viral
infect
cell
airway
tract
virus
shown
rs
viru
could
isol
macrophag
respiratori
tract
play
import
immunoregulatori
role
could
act
viral
reservoir
midulla
et
al
also
sever
exampl
latent
viral
infect
virus
famili
ie
paramyxovirida
measl
viru
subacut
scleros
panenceph
picornavirida
enteroviru
chronic
dilat
cardiomyopathi
therefor
time
could
exclud
possibl
rs
viru
rhinoviru
detect
repres
latent
infect
airway
tract
subsequ
minim
potenti
pathogen
role
hypothes
acut
exacerb
asthma
conclus
although
studi
could
address
issu
latent
infect
due
lack
control
group
result
obtain
nonetheless
interest
stimul
respiratori
virus
chlamydia
pneumonia
mycoplasma
pneumonia
alon
associ
detect
asthmat
exacerb
rhinoviru
rs
viru
frequent
isol
agent
although
mechan
asthma
fulli
understood
nadel
buss
one
import
issu
regard
role
respiratori
infect
develop
acut
exacerb
still
remain
unclear
studi
provid
groundwork
basi
clinic
virolog
studi
investig
specif
role
rs
viru
rhinoviru
develop
asthma
earli
life
well
induct
acut
exacerb
asthma
